Engineering and polymeric composition of drug‐eluting suture: A review. Issue 10 (8th April 2021)

• Record Type: Journal Article
• Authors: Deng, Xiaoxuan; Qasim, Muhammad; Ali, Azam
• Is Part Of: Journal of biomedical materials research. Volume 109:Issue 10(2021)
• Page Start: 2065
• Page End: 2081
• Publication Date: 2021-04-08
• Subjects: antimicrobial sutures -- drug‐eluting sutures -- fabrication techniques -- polymer sutures; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.a.37194
• Languages: English
• ISSNs: 1549-3296

Abstract

Abstract: Sutures are the most popular surgical implants in the global surgical equipment market. They are used for holding tissues together to achieve wound closure. However, controlling the body's immune response to these "foreign bodies" at site of infection is challenging. Natural polymers such as collagen, silk, nylon, and cotton, and synthetic polymers such as polycaprolactone, poly(lactic‐co‐glycolic acid), poly(p‐dioxanone) and so forth, contribute the robust foundation for the engineering of drug‐eluting sutures. The incorporation of active pharmaceutical ingredients (APIs) with polymeric composition of suture materials is an efficient way to reduce inflammatory reaction in the wound site as well as to control bacterial growth, while allowing wound healing. The incorporation of polymeric composition in surgical sutures has been found to add high flexibility as well as excellent physical and mechanical properties. Fabrication processes and polymer materials allow control over drug‐eluting profiles to effectively address wound healing requirements. This review outlines and discusses (a) polymer materials and APIs used in suture applications, including absorbable and nonabsorbable sutures; (b) suture structures, such as monofilament, multifilament, barded and smart sutures; and (c) the existing manufacturing techniques for drug‐eluting suture production, including electrospinning, melt‐extrusion and coating.